Director, Investor Relations

Quanterix is a global leader in ultra-sensitive biomarker detection, enabling breakthroughs in disease research, diagnostics, and drug development. Its vision is to lead the next era of precision biomarker science to power earlier detection, better decisions, and improved human health. Its mission is to make biology measurable at its most fundamental level, delivering earlier insight when it matters most. Across discovery to clinical applications, Quanterix empowers scientists and healthcare providers to improve patients' lives through detection and understanding of disease. Its proprietary Simoa technology delivers industry-leading sensitivity, allowing researchers to detect and quantify biomarkers in blood and other fluids at concentrations far below traditional limits. With more than 3,400 peer-reviewed publications, Quanterix has been a trusted partner to the scientific community for nearly two decades. In 2025, Quanterix acquired Akoya Biosciences, The Spatial Biology Company, adding multiplexed tissue imaging with single-cell resolution to its portfolio. Together, the combined company offers a uniquely integrated platform that connects biology across blood and tissue-advancing precision medicine from discovery to diagnostics.

We are seeking a Director, Investor Relations based in Billerica, MA. This role will serve as an important link between Quanterix and investors, analysts, and other key stakeholders in the investment community. The Director will continuously develop and help execute the Investor Relations program to ensure stakeholders, including investors, security analysts, senior management, and the Board of Directors, are well-informed about Quanterix's strategic and financial progress. Working closely with the CFO and cross-functional partners, this position will help manage day-to-day investor relations activities, develop external-facing communications, and support consistent messaging across investor interactions. Given Quanterix's dynamic, growth-oriented environment, the successful candidate must be a highly self-directed professional who can anticipate needs, manage priorities independently, and exercise sound judgment while staying closely aligned with senior leadership and company objectives. This role will report to the CFO.

* Support the creation of corporate and financial communications, including quarterly earnings press releases and scripts, earnings presentations, Q&A, investor presentations, press releases, IR website updates, backgrounders, and board materials.

* Help develop and execute a targeted investor relations strategy to support the Company's long-term value creation and ensure consistent messaging across investor communications.

* Manage updates to the Company's corporate presentation and support press releases for data releases, scientific meetings, presentations, and publications in close collaboration with Scientific Communications, Marketing and other internal partners.

* Build a strong understanding of the Company's corporate strategy; support clear and compelling communication of that strategy to internal and external audiences, in compliance with corporate policies and securities regulations.

* Support investor targeting efforts and maintain a target investor list. Monitor sell-side analyst models and earnings estimates, and help identify opportunities to expand institutional investor relationships and sell-side coverage.

* Maintain and help manage the IR calendar, including Company and executive participation in investor conferences, non-deal roadshows, and analyst/investor visits/meetings. Help create compelling ways to communicate upcoming developments, collaborating across company.

* Collect and analyze market data and prepare periodic feedback reports on stock price, analyst estimates, industry perceptions, and market trends for senior management, the Board and other stakeholders.

* Follow industry, competitor, and customer developments and news flow, including earnings calls and analyst days, and communicate key takeaways to management.

* Bachelor's degree in Finance, Accounting, Business Administration, Economics, Communications, Public Relations, or a related field.

* 10+ years of experience in investor relations, , equity research, corporate communications, or a related field.

* MBA preferred but not required.

* CFA preferred but not required.

* Experience working as a buy-side or sell-side analyst a plus.

* Preferred experience includes working in an investor relations agency or advisory environment, with exposure to a high volume of different company situations and a broad range of approaches to investor communications.

* Some experience in the life science tools space preferred.

* Hybrid role based in Billerica, MA. (3 days per week in office)

* Must be able to travel to investor meetings and conferences as needed.

* Strong verbal and written communication skills with the ability to develop clear, accurate executive-level materials with high attention to detail.

* Proactive, curious, and positive working style.

* Strong self-starter with the ability to operate with a high degree of independence, prioritize effectively in a fast-moving environment, and make thoughtful decisions while seeking input and alignment at the right moments.

* Strong financial and investment analysis skills, oral and written communication skills, and presentation ability.

* Working understanding of financial modeling techniques used by security analysts to project a company's operating and financial performance and the resulting value for its equity.

* Strong understanding of financial and investment markets with the ability to build relationships with investors, analysts, and internal stakeholders.

* Basic knowledge of SEC disclosure requirements and filings, accounting, and financial analysis.

* Strong understanding of the industry and market trends, competitive intelligence, and consumers.

* Highly organized and thoughtful with strong analytical and quantitative problem-solving skills.

* Proficiency in Microsoft Office, including Excel, PowerPoint, and Word.

Our Technology:

From discovery to diagnostics, Quanterix's ultrasensitive biomarker detection is fueling breakthroughs only made possible through its unparalleled sensitivity and flexibility. Simoa technology has delivered the gold standard for earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the Level of Quantification (LoQ). Our industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology, and infectious disease.

Akoya Biosciences, a Quanterix company, is The Spatial Biology Company-bringing tissue context to life through high-resolution, single-cell imaging. Akoya's spatial phenotyping platforms help researchers visualize and measure how cells organize and interact within tissue to influence disease progression and therapeutic response. From discovery through clinical research, Akoya offers a full continuum of solutions, including PhenoCycler, PhenoImager Fusion and HT, and PhenoCode Panels. As part of Quanterix, Akoya complements a leading portfolio of ultra-sensitive biomarker detection technologies, together enabling a more complete view of biology and disease across both tissue and blood.

At Quanterix, our values are based on: Team, Innovation, Customer and Owner.

Team: Challenge assumptions, not the person. Respect diversity of thought and hold ourselves to lofty standards

Innovation: Stay curious, experiment, create and change

Customer: Prioritize and celebrate these pioneers by doing our best to deliver on commitments

Owner: Act with high integrity and in the best interest of Quanterix. Take measured risks and learn from their success and failures.

We reward and recognize our employees by offering competitive compensation and a 401k plan with employer match, as well as competitive health, dental, and vision benefits for employees and their dependents. We also offer an unlimited vacation policy to all exempt employees, and a generous PTO policy for non-exempt employees. All employees are eligible for equity, employee stock purchase plan, a performance bonus, and 1:1 financial counseling/planning. We also offer Tuition Assistance. We have a free, state-of-the-art onsite fitness center for all employees. To keep you fueled up, we provide onsite employees free snacks and drinks every day!

Quanterix is committed to a Diverse and Inclusive workplace. We strive to recruit candidates who will bring inclusive mindsets and contribute to our values.

Quanterix is an Equal Opportunity Employer and does not discriminate based on race, national origin, gender, gender identity, sexual orientation, protected veteran status, disability, age, or other legally protected status. Quanterix will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.